Clinical Trial Update: Neoadjuvant Becotatug Vedotin Plus Pucotenlimab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma (OSCC) [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial evaluating Becotatug Vedotin plus Pucotenlimab in locally advanced oral and oropharyngeal squamous cell carcinoma; currently not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Squamous Cell Carcinoma
• Oropharyngeal Squamous Cell Carcinoma

Drugs mentioned

• Becotatug Vedotin
• Pucotenlimab

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING